Literature DB >> 26045783

FoxM1 influences mouse hepatocellular carcinoma metastasis in vitro.

Ningning Zhang1, Yunpeng Xie2, Benke Li3, Zhen Ning4, Aman Wang1, Xiaonan Cui1.   

Abstract

Lymph node metastasis is recognized as an important mode of liver cancer metastasis. Two hepatocarcinoma cell lines, Hca-F get high (75%) and Hca-P get low (25%) incidences of lymph node metastasis. Forkhead box M1 (FoxM1) is described as a major oncogenic transcription factor in tumor initiation, promotion, and progression. Ezrin is linked to aggressive tumor behavior by involving all stages of tumor metastasis. We firstly compared the expression of FoxM1 and Ezrin between two cells. Then we transiently transfected Hca-P cells with over-FoxM1 plasmid and Hca-F cells with sh-FoxM1 plasmid. We found that both FoxM1 and Ezrin expressed higher in Hca-F than Hca-P. We successfully down-regulated or up-regulated FoxM1 expression in Hca-F or Hca-P cells. And we found that FoxM1 had correlation with proliferation, invasion and migration in mouse hepatocellular carcinoma cell lines.

Entities:  

Keywords:  FoxM1; ezrin; hepatocarcinoma; lymphatic metastasis

Mesh:

Substances:

Year:  2015        PMID: 26045783      PMCID: PMC4440092     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  45 in total

Review 1.  Cortical actin organization: lessons from ERM (ezrin/radixin/moesin) proteins.

Authors:  S Tsukita; S Yonemura
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

2.  Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy.

Authors:  Shahab Uddin; Maqbool Ahmed; Azhar Hussain; Jehad Abubaker; Nasser Al-Sanea; Alaa AbdulJabbar; Luai H Ashari; Samar Alhomoud; Fouad Al-Dayel; Zeenath Jehan; Prashant Bavi; Abdul K Siraj; Khawla S Al-Kuraya
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 3.  Forkhead box M1 transcription factor: a novel target for cancer therapy.

Authors:  Zhiwei Wang; Aamir Ahmad; Yiwei Li; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Cancer Treat Rev       Date:  2009-12-22       Impact factor: 12.111

4.  FoxM1 influences embryo implantation and is regulated by 17 beta-estradiol and progesterone in mouse uteri and endometrium cells.

Authors:  Yunpeng Xie; Dan Cui; Ying Kong
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

5.  Prognostic implication of ezrin overexpression in myxofibrosarcomas.

Authors:  Hsuan-Ying Huang; Chien-Feng Li; Fu-Min Fang; Jen-Wei Tsai; Shau-Hsuan Li; Yuan-Ting Lee; Huei-Min Wei
Journal:  Ann Surg Oncol       Date:  2010-06-29       Impact factor: 5.344

6.  RACK1 promotes the proliferation, migration and invasion capacity of mouse hepatocellular carcinoma cell line in vitro probably by PI3K/Rac1 signaling pathway.

Authors:  Jun Wu; Jinyi Meng; Yue Du; Yuhong Huang; Yanling Jin; Jun Zhang; Bo Wang; Yuhong Zhang; Mingzhong Sun; Jianwu Tang
Journal:  Biomed Pharmacother       Date:  2013-02-18       Impact factor: 6.529

7.  Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression.

Authors:  Qiang Li; Nu Zhang; Zhiliang Jia; Xiangdong Le; Bingbing Dai; Daoyan Wei; Suyun Huang; Dongfeng Tan; Keping Xie
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

8.  The role of the membrane cytoskeleton cross-linker ezrin in medulloblastoma cells.

Authors:  Hirokatsu Osawa; Christian A Smith; Young Shin Ra; Paul Kongkham; James T Rutka
Journal:  Neuro Oncol       Date:  2008-12-16       Impact factor: 12.300

9.  FOXM1 confers acquired cisplatin resistance in breast cancer cells.

Authors:  Jimmy M-M Kwok; Barrie Peck; Lara J Monteiro; Helma D C Schwenen; Julie Millour; R Charles Coombes; Stephen S Myatt; Eric W-F Lam
Journal:  Mol Cancer Res       Date:  2010-01-12       Impact factor: 5.852

10.  Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells.

Authors:  Deborah A Sanders; Caryn S Ross-Innes; Dario Beraldi; Jason S Carroll; Shankar Balasubramanian
Journal:  Genome Biol       Date:  2013-01-24       Impact factor: 13.583

View more
  5 in total

1.  Exogenous delivery of microRNA-134 (miR-134) using α-tocopherol-based PEGylated liposome for effective treatment in skin squamous cell carcinoma.

Authors:  Chen Jing; Li Yan; Zhang Wei; Zhang Shoumin; Yin Guangwen; Zhang Jiangan; Jia Xuesong; Chen Hongxiang; Duan Ziyu; Li Jianguo
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

2.  Circulating exosomes potentiate tumor malignant properties in a mouse model of chronic sleep fragmentation.

Authors:  Abdelnaby Khalyfa; Isaac Almendros; Alex Gileles-Hillel; Mahzad Akbarpour; Wojciech Trzepizur; Babak Mokhlesi; Lei Huang; Jorge Andrade; Ramon Farré; David Gozal
Journal:  Oncotarget       Date:  2016-08-23

3.  Tanshinone IIA suppresses gastric cancer cell proliferation and migration by downregulation of FOXM1.

Authors:  Jiao Yu; Xiaoxia Wang; Yuhua Li; Bin Tang
Journal:  Oncol Rep       Date:  2017-01-30       Impact factor: 3.906

4.  Basic Transcription Factor 3 Is Required for Proliferation and Epithelial-Mesenchymal Transition via Regulation of FOXM1 and JAK2/STAT3 Signaling in Gastric Cancer.

Authors:  De-Zhong Zhang; Bing-He Chen; Lan-Fang Zhang; Ming-Kun Cheng; Xiang-Jie Fang; Xin-Jun Wu
Journal:  Oncol Res       Date:  2017-03-08       Impact factor: 5.574

5.  Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1.

Authors:  Yi Zhou; Zhigang Ji; Weigang Yan; Zhien Zhou; Hanzhong Li; Yu Xiao
Journal:  Oncol Rep       Date:  2017-06-29       Impact factor: 3.906

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.